LYPHOLYTE
LYPHOLYTE
Discontinued
DIN Number
02139618
Drug Class
Human
Market Date
Aug 14, 1996
Company
HC
Pharmaceutical Partners Of Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02139618
AIG Number0610335002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05XA30 COMBINATIONS OF ELECTROLYTES
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:12.00
Health Canada Classification
ACTIVE INGREDIENTS (6)
CALCIUM ACETATEActive
Strength: 440 MG / 20 ML
Monograph: CALCIUM ACETATE
MAGNESIUM ACETATEActive
Strength: 860 MG / 20 ML
Monograph: MAGNESIUM ACETATE
POTASSIUM ACETATEActive
Strength: 690 MG / 20 ML
Monograph: POTASSIUM ACETATE
POTASSIUM CHLORIDEActive
Strength: 2.5 G / 20 ML
Monograph: POTASSIUM CHLORIDE
SODIUM ACETATEActive
Strength: 2.7 G / 20 ML
Monograph: SODIUM ACETATE
SODIUM GLUCONATEActive
Strength: 1.1 G / 20 ML
Monograph: SODIUM GLUCONATE